CMV colitis: Difference between revisions

(Created page with "==Background== ==Clinical Presentation== ==Differential Diagnosis== ==Diagnosis== ==Management== ==Disposition== {{CMV colitis treatment}} ==See Also== ==External Links=...")
 
(Marked this version for translation)
 
(14 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Background==
<languages/>
<translate>


==Clinical Presentation==
==Background== <!--T:1-->


==Differential Diagnosis==
<!--T:2-->
*CMV is part of the Herpesviridae family
*50-80% of the world's population is seropositive for CMV
*Causes a mild or undetectable infection in immunocompetent hosts
*Severe systemic illness is found in immunosuppressed hosts


==Diagnosis==


==Management==
==Clinical Features== <!--T:3-->


==Disposition==
<!--T:4-->
*[[Special:MyLanguage/Fever|Fever]]
*Anorexia
*Malaise
*[[Special:MyLanguage/Abdominal pain|Abdominal pain]], Abdominal distention, [[Special:MyLanguage/constipation|constipation]]
*[[Special:MyLanguage/Nausea/vomiting|Nausea/vomiting]]
*Chronic watery [[Special:MyLanguage/diarrhea|diarrhea]]
*[[Special:MyLanguage/rectal bleeding|Bloody diarrhea]]
*Worsening symptoms of [[Special:MyLanguage/inflammatory bowel disease|inflammatory bowel disease]]
*Weight loss
*[[Special:MyLanguage/Dehydration|Dehydration]]
 
 
==Differential Diagnosis== <!--T:5-->
 
</translate>
{{Colitis DDX}}
<translate>
 
</translate>
{{CMV types}}
<translate>
 
 
==Evaluation== <!--T:6-->
 
 
==Management== <!--T:7-->
 
</translate>
{{CMV colitis treatment}}
{{CMV colitis treatment}}
==See Also==
<translate>
 
 
==Disposition== <!--T:8-->
 
 
==See Also== <!--T:9-->
 
<!--T:10-->
*[[Special:MyLanguage/Cytomegalovirus (CMV) infection|Cytomegalovirus (CMV) infection]]
 
 
==External Links== <!--T:11-->
 


==External Links==
==References== <!--T:12-->


==References==
<!--T:13-->
<references/>
<references/>
[[Category:ID]] [[Category:GI]]
</translate>

Latest revision as of 12:25, 7 January 2026

Other languages:

Background

  • CMV is part of the Herpesviridae family
  • 50-80% of the world's population is seropositive for CMV
  • Causes a mild or undetectable infection in immunocompetent hosts
  • Severe systemic illness is found in immunosuppressed hosts


Clinical Features


Differential Diagnosis

Colitis

CMV Diseases


Evaluation

Management

  • Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
  • Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)


Disposition

See Also


External Links

References